Finally, meningiomas in the third group have a high chromosomal instability and proliferation index, may feature pTERT mutations and/or CDKN2A/B HoDe, have the worst prognosis, and are resistant to cytotoxic drugs. This evidence concerns the gene CDKN2A and meningioma.